Novartis Vaccines and Diagnostics
Novartis
12
0
12
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+24 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (12)
Showing 10 of 12 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Novartis vaccines and Diagnostics
Novartis Vaccines
Shared therapeutic areas:
Worked with same sponsors:
General Manager
Tanabe Pharma Corporation
Shared therapeutic areas:
Veryl Hodges, DO
Clopton Clinic
Shared therapeutic areas:
Shaukat A. Shah, MD
St. Joseph's Medical Associates, Stockton, CA 95204
Shared therapeutic areas:
Keith S. Reisinger, MD, MPH
Primary Physicians Research, Inc
Shared therapeutic areas:
Giuseppe D'Ignazio, MD
Source Unique Clinic
Shared therapeutic areas:
Seetha Shankaran, MD
Wayne State University
Shared therapeutic areas:
Michele C. Walsh, MD MS
Case Western Reserve University, Rainbow Babies and Children's Hospital
Shared therapeutic areas:
Carl T D'Angio, MD
University of Rochester
Shared therapeutic areas:
John Champlin, MD
Medical Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (12)
Showing 12 of 12 trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults
Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults
B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents
Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children
Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old
Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)
Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age
Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules
All 12 trials loaded